Literature DB >> 29024475

Bioengineered lungs generated from human iPSCs-derived epithelial cells on native extracellular matrix.

Mahboobe Ghaedi1,2, Andrew V Le1,2, Go Hatachi1,2, Arkadi Beloiartsev1,2, Kevin Rocco1,2, Amogh Sivarapatna1,2, Julio J Mendez1,2, Pavlina Baevova1,2, Rachel N Dyal3, Katie L Leiby1,2, Eric S White3, Laura E Niklason1,2.   

Abstract

The development of an alternative source for donor lungs would change the paradigm of lung transplantation. Recent studies have demonstrated the potential feasibility of using decellularized lungs as scaffolds for lung tissue regeneration and subsequent implantation. However, finding a reliable cell source and the ability to scale up for recellularization of the lung scaffold still remain significant challenges. To explore the possibility of regeneration of human lung tissue from stem cells in vitro, populations of lung progenitor cells were generated from human iPSCs. To explore the feasibility of producing engineered lungs from stem cells, we repopulated decellularized human lung and rat lungs with iPSC-derived epithelial progenitor cells. The iPSCs-derived epithelial progenitor cells lined the decellularized human lung and expressed most of the epithelial markers when were cultured in a lung bioreactor system. In decellularized rat lungs, these human-derived cells attach and proliferate in a manner similar to what was observed in the decellularized human lung. Our results suggest that repopulation of lung matrix with iPSC-derived lung epithelial cells may be a viable strategy for human lung regeneration and represents an important early step toward translation of this technology.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  decellularized lung; epithelial cells; induced pluripotent stem cell (iPSC); lung implant; tissue regeneration bioreactor

Mesh:

Substances:

Year:  2017        PMID: 29024475      PMCID: PMC5991621          DOI: 10.1002/term.2589

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  43 in total

1.  Bioartificial tissues and organs: are we ready to translate?

Authors:  Harald C Ott; Douglas J Mathisen
Journal:  Lancet       Date:  2011-11-24       Impact factor: 79.321

Review 2.  Cell-based therapies for lung disease.

Authors:  Orquidea Garcia; Gianni Carraro; Sonia Navarro; Ivan Bertoncello; Jonathan McQualter; Barbara Driscoll; Edwin Jesudason; David Warburton
Journal:  Br Med Bull       Date:  2012-01-25       Impact factor: 4.291

Review 3.  Epithelial stem cells of the lung: privileged few or opportunities for many?

Authors:  Emma L Rawlins; Brigid L M Hogan
Journal:  Development       Date:  2006-05-30       Impact factor: 6.868

4.  Stem cells and cell therapies in lung biology and diseases: conference report.

Authors:  Daniel J Weiss; Jason H T Bates; Thomas Gilbert; W Conrad Liles; Carolyn Lutzko; Jay Rajagopal; Darwin Prockop
Journal:  Ann Am Thorac Soc       Date:  2013-10

5.  Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded.

Authors:  Andrew P Price; Kristen A England; Amy M Matson; Bruce R Blazar; Angela Panoskaltsis-Mortari
Journal:  Tissue Eng Part A       Date:  2010-08       Impact factor: 3.845

6.  Regenerative medicine for the respiratory system: distant future or tomorrow's treatment?

Authors:  Katrien M Brouwer; Henk R Hoogenkamp; Willeke F Daamen; Toin H van Kuppevelt
Journal:  Am J Respir Crit Care Med       Date:  2012-12-06       Impact factor: 21.405

Review 7.  Building and maintaining the epithelium of the lung.

Authors:  Craig R Rackley; Barry R Stripp
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

8.  Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening.

Authors:  Payal Rana; Blake Anson; Sandra Engle; Yvonne Will
Journal:  Toxicol Sci       Date:  2012-07-27       Impact factor: 4.849

9.  Derivation of type II alveolar epithelial cells from murine embryonic stem cells.

Authors:  Nadire N Ali; Alasdair J Edgar; Ali Samadikuchaksaraei; Catherine M Timson; Hanna M Romanska; Julia M Polak; Anne E Bishop
Journal:  Tissue Eng       Date:  2002-08

10.  Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix.

Authors:  Mahboobe Ghaedi; Elizabeth A Calle; Julio J Mendez; Ashley L Gard; Jenna Balestrini; Adam Booth; Peter F Bove; Liqiong Gui; Eric S White; Laura E Niklason
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

View more
  14 in total

Review 1.  Bioengineering the Blood-gas Barrier.

Authors:  Katherine L Leiby; Micha Sam Brickman Raredon; Laura E Niklason
Journal:  Compr Physiol       Date:  2020-03-12       Impact factor: 9.090

2.  High-Throughput Culture Method of Induced Pluripotent Stem Cell-Derived Alveolar Epithelial Cells.

Authors:  David Becerra; Tong Wu; Sydney Jeffs; Harald C Ott
Journal:  Tissue Eng Part C Methods       Date:  2021-12       Impact factor: 3.056

Review 3.  Lung Extracellular Matrix as a Platform for Lung Organ Bioengineering: Design and Development of Tissue Engineered Lung.

Authors:  Shabnam Sabetkish; Abdol-Mohammad Kajbafzadeh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Cell Inertia: Predicting Cell Distributions in Lung Vasculature to Optimize Re-endothelialization.

Authors:  Jason K D Chan; Eric A Chadwick; Daisuke Taniguchi; Mohammadali Ahmadipour; Takaya Suzuki; David Romero; Cristina Amon; Thomas K Waddell; Golnaz Karoubi; Aimy Bazylak
Journal:  Front Bioeng Biotechnol       Date:  2022-04-27

Review 5.  Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery.

Authors:  Arun Sharma; Samuel Sances; Michael J Workman; Clive N Svendsen
Journal:  Cell Stem Cell       Date:  2020-03-05       Impact factor: 24.633

Review 6.  Lung bioengineering: advances and challenges in lung decellularization and recellularization.

Authors:  Juan J Uriarte; Franziska E Uhl; Sara E Rolandsson Enes; Robert A Pouliot; Daniel J Weiss
Journal:  Curr Opin Organ Transplant       Date:  2018-12       Impact factor: 2.640

Review 7.  Bioengineering platforms for cell therapeutics derived from pluripotent and direct reprogramming.

Authors:  Yoonhee Jin; Seung-Woo Cho
Journal:  APL Bioeng       Date:  2021-07-06

Review 8.  Role of Bioreactor Technology in Tissue Engineering for Clinical Use and Therapeutic Target Design.

Authors:  Clare Selden; Barry Fuller
Journal:  Bioengineering (Basel)       Date:  2018-04-24

Review 9.  Lung Microvascular Niche, Repair, and Engineering.

Authors:  Tomoshi Tsuchiya; Ryoichiro Doi; Tomohiro Obata; Go Hatachi; Takeshi Nagayasu
Journal:  Front Bioeng Biotechnol       Date:  2020-02-21

10.  Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing.

Authors:  Sally Esmail; Wayne Danter
Journal:  Stem Cells Transl Med       Date:  2020-09-22       Impact factor: 7.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.